Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway

Int Rev Neurobiol. 2004:59:425-44. doi: 10.1016/S0074-7742(04)59016-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / physiology*
  • Denervation / methods
  • Depression / metabolism
  • Dopamine / metabolism*
  • Dopamine Agents / adverse effects
  • Gene Expression Regulation, Developmental
  • Humans
  • Levodopa / adverse effects
  • Limbic System / cytology
  • Limbic System / growth & development
  • Limbic System / metabolism*
  • Neuronal Plasticity / physiology*
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / genetics
  • Receptors, Dopamine D2 / metabolism*
  • Receptors, Dopamine D3
  • Schizophrenia / metabolism
  • Stress, Physiological / metabolism

Substances

  • Brain-Derived Neurotrophic Factor
  • DRD3 protein, human
  • Dopamine Agents
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Levodopa
  • Dopamine